$35 Million Funding for Telehealth Addiction Treatment Provider
Pioneer in telehealth addiction treatment, Boulder Care, secures $35 million in funding for rural expansion.
Ozempic Maker to Study Its Effect on Alcohol Consumption
Novo Nordisk, the maker of Ozempic, plans to study the drug’s effect on alcohol consumption.
Semaglutide As Potential Addiction Therapy
Recently, there has been growing interest in another possible use for GLP-1 weight loss and diabetes drugs — to treat addiction.
Investigative Journalist Takes a Hard Look at California’s Addiction Treatment Programs
Watchdog Columnist Teri Sforza attends ASAM55 and comes away with a few suggestions for California Governor Gavin Newsom.
Telehealth Company, Pelago, Raises Additional $58 Million in Venture Capital Funding
Virtual clinic, Pelago, raises $58 million for expansion in remote delivery of substance use disorder treatment.
Drug Companies “Apathetic” About Testing GLP-1 Drugs to Treat Substance Use Disorders
Early studies of GLP-1 drugs for substance abuse treatment show promise, but drug companies are slow to fund research.